We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$83.1M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$43.8M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$40.2M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$26.6M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRAM icon
4326
Everspin Technologies
MRAM
$410M
$10K ﹤0.01%
1,535
+1,140
+289% +$6.99K
NCMI icon
4327
National CineMedia
NCMI
$252M
$10K ﹤0.01%
292
-1,362
-82% -$44.2K
NCSM icon
4328
NCS Multistage Holdings
NCSM
$132M
$10K ﹤0.01%
334
-113
-25% -$3.1K
NRXP icon
4329
NRX Pharmaceuticals
NRXP
$143M
$10K ﹤0.01%
103
+90
+692% +$11.7K
PANW icon
4330
Palo Alto Networks
PANW
$323B
$10K ﹤0.01%
126
-3,492
-97% -$245K
PVBC
4331
DELISTED
Provident Bancorp
PVBC
$10K ﹤0.01%
619
-287
-32% -$4.63K
RDVT icon
4332
Red Violet
RDVT
$1.18B
$10K ﹤0.01%
383
-188
-33% -$4.97K
REPX icon
4333
Riley Exploration Permian
REPX
$786M
$10K ﹤0.01%
428
+207
+94% +$4.4K
STKS icon
4334
The ONE Group
STKS
$56.8M
$10K ﹤0.01%
981
-2,018
-67% -$20.8K
TAOP icon
4335
Taoping
TAOP
$8.83M
$10K ﹤0.01%
+12
New +$12.1K
TARS icon
4336
Tarsus Pharmaceuticals
TARS
$3.02B
$10K ﹤0.01%
465
-708
-60% -$17.5K
TNYA icon
4337
Tenaya Therapeutics
TNYA
$164M
$10K ﹤0.01%
+479
New +$10.3K
TRML
4338
DELISTED
Tourmaline Bio
TRML
$10K ﹤0.01%
79
+73
+1,217% +$9.99K
URG
4339
Ur-Energy
URG
$533M
$10K ﹤0.01%
5,770
-20,583
-78% -$27.6K
URGN icon
4340
UroGen Pharma
URGN
$2.34B
$10K ﹤0.01%
600
-2,694
-82% -$42.7K
USLM icon
4341
United States Lime & Minerals
USLM
$3.37B
$10K ﹤0.01%
410
-285
-41% -$7.93K
UTG icon
4342
Reaves Utility Income Fund
UTG
$3.69B
$10K ﹤0.01%
+305
New +$10.7K
VERA icon
4343
Vera Therapeutics
VERA
$2.08B
$10K ﹤0.01%
+605
New +$10.8K
VGK icon
4344
Vanguard FTSE Europe ETF
VGK
$31.1B
$10K ﹤0.01%
142
-15,570
-99% -$1.07M
VRCA icon
4345
Verrica Pharmaceuticals
VRCA
$83.5M
$10K ﹤0.01%
77
-159
-67% -$17.8K
VRNA
4346
DELISTED
Verona Pharma
VRNA
$10K ﹤0.01%
1,777
+412
+30% +$2.4K
XBIT icon
4347
XBiotech
XBIT
$71M
$10K ﹤0.01%
800
-704
-47% -$11.2K
XPOF icon
4348
Xponential Fitness
XPOF
$206M
$10K ﹤0.01%
+804
New +$9.34K
NIXX
4349
Nixxy Inc
NIXX
$19.8M
$10K ﹤0.01%
+190
New +$12.2K
OKUR
4350
OnKure Therapeutics
OKUR
$158M
$10K ﹤0.01%
130
+126
+3,150% +$10.7K
172 173
174
175 176

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.